Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality
about
How to select the best available related or unrelated donor of hematopoietic stem cells?Human Leukocyte Antigen Diversity: A Southern African PerspectiveHLA-C Incompatibilities in Allogeneic Unrelated Hematopoietic Stem Cell TransplantationHLA class I molecular variation and peptide-binding properties suggest a model of joint divergent asymmetric selection.Acute graft-versus-host disease: a bench-to-bedside update.Predicting alloreactivity in transplantation.Role of major histocompatibility complex variation in graft-versus-host disease after hematopoietic cell transplantation.Clinical implications of HLA locus mismatching in unrelated donor hematopoietic cell transplantation: a meta-analysisNonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.Association between CTL Precursor Frequency to HLA-C Mismatches and HLA-C Antigen Cell Surface Expression.HLA-C expression levels define permissible mismatches in hematopoietic cell transplantationBiological significance of HLA locus matching in unrelated donor bone marrow transplantation.Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donor.Zooming into the binding groove of HLA molecules: which positions and which substitutions change peptide binding most?Allorecognition of HLA-C Mismatches by CD8+ T Cells in Hematopoietic Stem Cell Transplantation Is a Complex Interplay between Mismatched Peptide-Binding Region Residues, HLA-C Expression, and HLA-DPB1 Disparities.Identification of a permissible HLA mismatch in hematopoietic stem cell transplantationUsing HLA typing to support patients with cancer.Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015.Altered homeostatic regulation of innate and adaptive immunity in lower gastrointestinal tract GVHD pathogenesis.Understanding the obstacle of incompatibility at residue 156 within HLA-B*35 subtypes.Identification of high-risk amino-acid substitutions in hematopoietic cell transplantation: a challenging task.BSHI Guideline: HLA matching and donor selection for haematopoietic progenitor cell transplantation.Mismatched unrelated donor transplantation.In celebration of Ruggero Ceppellini: HLA in transplantation.Soluble HLA technology as a strategy to evaluate the impact of HLA mismatches.From genetic single candidate gene studies to complex genomics of GvHD.Physiochemical disparity of mismatched HLA class I alloantigens and risk of acute GVHD following HSCT.Predicting relevant immunogenetic disparities.Dynamical system modeling to simulate donor T cell response to whole exome sequencing-derived recipient peptides: Understanding randomness in alloreactivity incidence following stem cell transplantation.Genomic sequences of two novel HLA-C alleles, HLA-C*15:143 and HLA-C*07:109:02.Alloimmune T cells in transplantation.Major Histocompatibility Complex and Hematopoietic Stem Cell Transplantation: Beyond the Classical HLA Polymorphism.Human Leukocyte Antigen-A, B, C, DRB1, and DQB1 Allele and Haplotype Frequencies in a Subset of 237 Donors in the South African Bone Marrow Registry.
P2860
Q26744109-C7F9B470-F2AF-49B8-B8F2-8A964767779BQ26782686-CFC9FAE4-1612-4200-AD39-B7D90E49D21DQ27022939-5D29E64C-8469-44E7-959A-736FE0A3367CQ27324007-60AF2E29-5020-4910-A676-4A66F7EF7F94Q27687130-87B872A3-7146-4B53-A6F7-5773D42C88B1Q33608371-88255C7A-4127-470F-B43F-42220AE90484Q33642419-7874F24D-B5C2-403A-A5DD-C858144F9A8CQ33689153-AEA94444-6A54-4373-BDA5-F7E1CA075264Q34353744-ABC9AA94-CEB1-46E3-96B1-C74D25ABDC4CQ34406850-332FEBE8-1E1F-4406-900D-20892E8AD9D2Q34737555-00D18673-83BE-44F6-8ADF-097529A7EC65Q35080101-F1E7F156-609B-4D37-A681-1E0E3269DFA3Q35108791-63768DA3-C0B7-4B8C-AF04-9C8A04005904Q35837827-1A0CE352-FEBC-4345-946B-AC1958A106A3Q37494315-45D251F5-22ED-4EFA-9952-03F88D96BB83Q37596625-8FF99C1A-953C-4644-AFE1-AC2260D35911Q38287616-CF4E87BA-D640-4A49-BC35-22D22BD754D6Q38387292-E0803CAC-E365-44BB-98E9-39A3E98743BDQ38743931-60C7976B-D9A6-4F36-8E56-6CC9C00B90C1Q38804389-3CAA68FC-6123-4C1F-8607-8460B59CFFD5Q38841732-7C6D770C-7249-4AB9-858A-DFD85EDE0510Q38922475-ACB34F34-BBB1-40E4-909C-51207EB832F4Q38992834-CDBF3E01-9720-4DD2-8202-20ACBE79844DQ39094693-6118444F-6494-41F3-BE9A-DFFD8508F0F3Q39123538-067E4F6D-54E6-400F-9BAE-2633C58CEE8FQ39263959-3E8DDFC2-DD5F-4F87-93FF-FFBFB6C0B0C1Q41525587-562956D1-2E7C-45E9-ABE7-09207CC8F1B0Q42428458-D9A21079-EC4B-4C61-88FE-9D9B3BF9FA0AQ45074498-FA1DB312-91D6-41AB-B294-571F622E3DD5Q48146706-1E726FAE-DAFB-4E31-85E3-EA4C1165CE97Q50936985-8AA0739E-E75B-4029-BCD6-F7E013EA5301Q52374806-17F2E563-F9E3-45D2-9668-0D4622886559Q55116544-AA70E8CE-FF93-4517-959B-547098AB19D0
P2860
Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Amino acid substitution at pep ...... evere acute GVHD and mortality
@en
Amino acid substitution at pep ...... vere acute GVHD and mortality.
@nl
type
label
Amino acid substitution at pep ...... evere acute GVHD and mortality
@en
Amino acid substitution at pep ...... vere acute GVHD and mortality.
@nl
prefLabel
Amino acid substitution at pep ...... evere acute GVHD and mortality
@en
Amino acid substitution at pep ...... vere acute GVHD and mortality.
@nl
P2093
P2860
P50
P1433
P1476
Amino acid substitution at pep ...... evere acute GVHD and mortality
@en
P2093
Ann A Jakubowski
Ann E Woolfrey
Claudio Anasetti
E Victoria Turner
Elizabeth Trachtenberg
Jeanne Palmer
Joseph Pidala
Lee Ann Baxter-Lowe
Machteld Oudshoorn
Manish Gandhi
P2860
P304
P356
10.1182/BLOOD-2013-05-501510
P407
P577
2013-08-27T00:00:00Z